Impurity profile study of cefalotin sodium by two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry

doi:10.3724/SP.J.1123.2015.07027

Abstract

Abstract:

A two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry (2D-LC-QTOF MS) method to profile the impurities of cefalotin sodium was developed. A Symmetry C18 column (250 mm×4.6 mm, 5 μm) was used in the first dimensional chromatography, with gradient elution using pH 2.5 phosphate buffer and acetonitrile as the mobile phases. The column temperature was maintained at 40 ℃ with an ultraviolet detection of 220 nm for analysis. An ACQUITY UPLC BEH C18 column (50 mm×2.1 mm, 1.7 μm) was used in the second dimensional chromatography, with gradient elution using water containing 0.1% (v/v) formic acid and acetonitrile containing 0.1% (v/v) formic acid as the mobile phases. The column temperature was maintained at 40 ℃. An HLB C18 column (30 mm×2.1 mm, 20 μm) was used as the trap column. The data were collected in positive ion mode. The ion source temperature was set at 100 ℃ and the electrospray ionization (ESI) needle voltage was set at 1000 V. The nebulizer gas temperature was set at 500 ℃. The molecular formulas of the impurities were determined by their exact masses and isotope distributions. And the structures were determined by the protonated molecular ions and the manufacturing process of cefalotin sodium. Six impurities of cefalotin sodium were characterized and the origination of the impurities was deduced. Three of them were unknown impurities to the best of our knowledge. It was confirmed that the Chinese Pharmacopoeia 2010 has mistaken impurity A of cefalotin sodium. The results indicated that the 2D-LC-QTOF MS method could be used to investigate the impurity profile of cefalotin sodium, and it is simple and sensitive.

Key words: cefalotin sodium, impurity profile, two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry (2D-LC-QTOF MS)

CLC Number:

O658

QIU Ya, QIN Feng, WEN Hongliang, ZHAO Jingdan, LIU Hao, YANG Meicheng. Impurity profile study of cefalotin sodium by two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry[J]. Chinese Journal of Chromatography, 2015, 33(12): 1314-1319.

References

[1] Salwa R E, Gamal A S, Fardous A M, et al. J Pharm Biomed Anal, 2007, 45: 1
[2] Xue Y, Chen Y Y. Chinese Journal of Antibiotics (薛雨, 陈宇瑛. 中国抗生素杂志), 2011, 36(2): 86
[3] Mo J N, Li W, Wen Y Y, et al. Chinese Pharmaceutical Affairs (莫金娜, 李汶, 温玉莹, 等. 中国药事), 2010, 24(8): 750
[4] Han P, Zhang P P. Drug Standards of China (韩鹏, 张培培. 中国药品标准), 2007, 8(2): 19
[5] Hu M, Hu C Q, Liu W Y. Chinese Journal of Pharmaceutical Analysis (胡敏, 胡昌勤, 刘文英. 药物分析杂志), 2005, 25(3): 369
[6] Hu C Q, Jiang Y, Zhang J P, et al. Chinese Journal of New Drug (胡昌勤, 蒋煜, 张靖溥, 等. 中国新药杂志), 2013, 22(1): 4
[7] Hu C Q. Scientia Sinica Chimica (胡昌勤. 中国科学: 化学), 2010, 40(6): 679
[8] Mallikarjun N, Tarun H, Parul S, et al. J Pharm Biomed Anal, 2014, 87: 191
[9] Ravi N T, Nishit S, Vikas B, et al. J Pharm Anal, 2015, 5(1): 33
[10] Li J, Huang H W, Zhang H, et al. Acta Pharmaceutica Sinica (李婕, 黄海伟, 张红, 等. 药学学报), 2014, 49(5): 672
[11] Song D M, Ren M T, Duan G L. Chinese Journal of Pharmaceutical Analysis (宋东梅, 任美婷, 段更利. 药物分析杂志), 2012, 32(8): 1468
[12] Gao H, Wen X S, Ma X J, et al. Chinese Journal of Pharmaceutical Analysis (高辉, 温学森, 马小军, 等. 药物分析杂志), 2007, 27(4): 616
[13] Wang Z C, Zhang Q H, Zhao Z Y, et al. Chinese Journal of Analytical Chemistry (王智聪, 张庆合, 赵忠一, 等. 分析化学), 2005, 33(5): 722
[14] Yang M C, Qin F, Liu H, et al. Chinese Journal of Pharmaceutical Analysis (杨美成, 秦峰, 刘浩, 等. 药物分析杂志), 2014, 34(8): 1449
[15] Liu H, Jia Z Q. Chinese Journal of Antibiotics (刘浩, 贾志强. 中国抗生素杂志), 2013, 38(12): 921
[16] Pharmacopoeia Commission of People's Republic of China. Pharmacopoeia of People's Republic of China, Part 2. Beijing: China Medical Science Press (国家药典委员会. 中华人民共和国药典, 二部. 北京: 中国医药科技出版社), 2010: 215
[17] Yang M C, Liu H, Qiu Y, et al. J Liq Chromatogr Related Technol, 2015, 38(7): 816
[18] Pharmacopoeia Commission of People's Republic of China. Pharmacopoeia Notes of Pharmacopoeia of People's Republic of China 1990 Part 2. Beijing: Chemical Industry Press (国家药典委员会. 中华人民共和国药典1990年版二部药典注释. 北京: 化学工业出版社), 1993: 175